{"transactions":[{"id":1784690,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-08T16:00:25.000Z","date":"2023-09-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":129222,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated as of June 15, 2023 (the \"Merger Agreement\"), by and among the Issuer, Coherus BioSciences, Inc. (\"Coherus\"), Crimson Merger Sub I, Inc., a direct, wholly owned subsidiary of Coherus (\"Merger Sub I\"), and Crimson Merger Sub II, LLC, a direct, wholly owned subsidiary of Coherus (\"Merger Sub II\"), pursuant to which Merger Sub I merged with and into the Issuer effective as of September 8, 2023 (the \"Effective Time\"), with Surface surviving such merger as a direct, wholly owned subsidiary of Coherus (the \"First Merger\"), and, as part of the same overall transaction, promptly after the First Merger, the surviving corporation of the First Merger merged with and into Merger Sub II, with Merger Sub II surviving such merger."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each issued and outstanding share of common stock of the Issuer was cancelled and converted into the right to receive (i) 0.1960 (the \"Exchange Ratio\") shares of common stock of Coherus and (ii) one contingent value right (each, a \"CVR\") representing a contractual right to receive contingent future conditional payments pursuant to the terms of a Contingent Value Rights Agreement by and between Coherus and Computershare Inc."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-048758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919123048758/doc4.xml","form_type":"4"}},{"id":2112176,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-17T21:09:22.000Z","date":"2022-11-16","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 3, 2022, by and among the Company, Alexion Pharmaceuticals, Inc. (\"Parent\") and Camelot Merger Sub, Inc. (\"Merger Sub\"), on November 16, 2022 (the \"Effective Time\"), Merger Sub merged with and into the Company (the \"Merger\"), with the Company continuing as the surviving corporation in the Merger and as a wholly-owned subsidiary of Parent, and, at the Effective Time, each option was cancelled pursuant to the terms of the Merger Agreement; provided, that each option with a per share exercise price equal to or greater than $2.07 was automatically cancelled for no consideration. For more information see the Solicitation/Recommendation Statement on Schedule 14D-9 filed by the Company with the United States Securities and Exchange Commission on October 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on June 17, 2022. The options were scheduled to vest in full on the earlier of (i) the first anniversary of the grant date, and (ii) the day prior to the 2023 Annual Meeting of Stockholders of LogicBio Therapeutics, Inc. (the \"Company\"), subject to the Reporting Person's continued service with the Company on the vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.38,"expiration_date":"2032-06-17","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-22-036298","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656435/000089924322036298/doc4.xml","form_type":"4"}},{"id":2225431,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T08:08:24.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The options were granted by LogicBio Therapeutics, Inc. (the \"Company\") pursuant to its 2018 Equity Incentive Plan, as provided under the Company's current non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the earlier of (i) the first anniversary of the grant date, and (ii) the day prior to the Company's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service with the Company on the vesting date."}],"balance_after":12500,"derivative":{"exercise_price":0.38,"expiration_date":"2032-06-17","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-22-038236","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656435/000120919122038236/doc4.xml","form_type":"4"}},{"id":2236073,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T20:00:12.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options shall vest in twelve equal monthly installments following the date of grant or, if earlier, upon the date of the next Annual Meeting; provided, however, that all vesting shall cease if the director resigns from the Board of Directors or otherwise ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting."}],"balance_after":24000,"derivative":{"exercise_price":2.01,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-22-036144","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919122036144/doc4.xml","form_type":"4"}},{"id":2434955,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-14T20:30:37.000Z","date":"2021-07-21","kind":"sale","acquired":false,"shares":127778,"price":6.1,"value":779445.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Amount reported represents the number of shares sold by the reporting person to cover the tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":129222,"source":{"system":"sec-edgar","filing":"0001209191-22-003400","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919122003400/doc4.xml","form_type":"4"}},{"id":2670193,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T20:01:05.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted by the Issuer pursuant to its 2018 Equity Incentive Plan as provided under the Company's compensation policy for non-employee directors. All of the options will vest and become exercisable on the earlier of (i) the first anniversary of the grant date, and (ii) the day prior to the Company's 2022 annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer through the vesting date."}],"balance_after":12500,"derivative":{"exercise_price":4.59,"expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-21-040429","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656435/000120919121040429/doc4.xml","form_type":"4"}},{"id":2672108,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T20:30:12.000Z","date":"2021-06-11","kind":"exercise","acquired":false,"shares":10273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested and exercisable as of the date hereof."}],"balance_after":93831,"derivative":{"exercise_price":4.14,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":10273},"source":{"system":"sec-edgar","filing":"0001209191-21-040078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121040078/doc4.xml","form_type":"4"}},{"id":2672107,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T20:30:12.000Z","date":"2021-06-10","kind":"exercise","acquired":false,"shares":34727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests and becomes exercisable in 48 equal monthly installments after the closing of the Issuer's initial public offering."}],"balance_after":10325,"derivative":{"exercise_price":4.14,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":34727},"source":{"system":"sec-edgar","filing":"0001209191-21-040078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121040078/doc4.xml","form_type":"4"}},{"id":2672106,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T20:30:12.000Z","date":"2021-06-10","kind":"exercise","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested and exercisable as of the date hereof."}],"balance_after":104104,"derivative":{"exercise_price":4.14,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-21-040078","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121040078/doc4.xml","form_type":"4"}},{"id":2672105,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T20:30:12.000Z","date":"2021-06-11","kind":"sale","acquired":false,"shares":15273,"price":7.6099,"value":116226.0027,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $7.58 to $7.64. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":257000,"source":{"system":"sec-edgar","filing":"0001209191-21-040078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121040078/doc4.xml","form_type":"4"}},{"id":2672104,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T20:30:12.000Z","date":"2021-06-11","kind":"exercise","acquired":true,"shares":10273,"price":4.14,"value":42530.22,"ownership":{"direct":true},"balance_after":272273,"source":{"system":"sec-edgar","filing":"0001209191-21-040078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121040078/doc4.xml","form_type":"4"}},{"id":2672103,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T20:30:12.000Z","date":"2021-06-10","kind":"sale","acquired":false,"shares":234727,"price":7.6626,"value":1798619.1102,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $7.56 to $7.82. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":262000,"source":{"system":"sec-edgar","filing":"0001209191-21-040078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121040078/doc4.xml","form_type":"4"}},{"id":2672102,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T20:30:12.000Z","date":"2021-06-10","kind":"exercise","acquired":true,"shares":34727,"price":4.14,"value":143769.78,"ownership":{"direct":true},"balance_after":496727,"source":{"system":"sec-edgar","filing":"0001209191-21-040078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121040078/doc4.xml","form_type":"4"}},{"id":2672101,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T20:30:12.000Z","date":"2021-06-10","kind":"exercise","acquired":true,"shares":200000,"price":4.14,"value":828000.0,"ownership":{"direct":true},"balance_after":462000,"source":{"system":"sec-edgar","filing":"0001209191-21-040078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121040078/doc4.xml","form_type":"4"}},{"id":2716397,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-12T16:27:14.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":28586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":28586,"derivative":{"exercise_price":2.15,"exercise_date":"2022-05-11","underlying":"Common Stock","underlying_shares":28586},"source":{"system":"sec-edgar","filing":"0000891839-21-000140","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1656435/000089183921000140/edgar.xml","form_type":"4"}},{"id":2761472,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T20:25:22.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":4425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option shall vest monthly from  April 1, 2022 through the earlier of (i) June 30, 2022 and (ii) the last date of reporting person's Service Relationship."}],"balance_after":4425,"derivative":{"exercise_price":8.09,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":4425},"source":{"system":"sec-edgar","filing":"0001209191-21-024886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121024886/doc4.xml","form_type":"4"}},{"id":2761471,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T20:25:22.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":35400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest in full on March 31, 2022; subject to the reporting person's Service Relationship on such date."}],"balance_after":35400,"derivative":{"exercise_price":8.09,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":35400},"source":{"system":"sec-edgar","filing":"0001209191-21-024886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121024886/doc4.xml","form_type":"4"}},{"id":2761470,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T20:25:22.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests monthly through the earlier of (i) March 31, 2022 and (ii) the last date of the reporting person's last day of their Service Relationship."}],"balance_after":15000,"derivative":{"exercise_price":8.09,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-024886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121024886/doc4.xml","form_type":"4"}},{"id":2761469,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T20:25:22.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly through the earlier of  (i) September 30, 2021 and (ii) the last date of the reporting person's last day of their Service Relationship"}],"balance_after":15000,"derivative":{"exercise_price":8.09,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-024886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121024886/doc4.xml","form_type":"4"}},{"id":2872047,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-09T20:00:13.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall become exercisable in equal monthly installments over four years following January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such dates."}],"balance_after":247000,"derivative":{"exercise_price":3.18,"expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-21-009056","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121009056/doc4.xml","form_type":"4"}},{"id":2872046,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-09T20:00:13.000Z","date":"2021-02-08","kind":"sale","acquired":false,"shares":2500,"price":12.5,"value":31250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020."}],"balance_after":262000,"source":{"system":"sec-edgar","filing":"0001209191-21-009056","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121009056/doc4.xml","form_type":"4"}},{"id":2872045,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-09T20:00:13.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":2500,"price":3.18,"value":7950.0,"ownership":{"direct":true},"balance_after":264500,"source":{"system":"sec-edgar","filing":"0001209191-21-009056","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121009056/doc4.xml","form_type":"4"}},{"id":2882016,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-03T20:00:35.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall become exercisable in equal monthly installments over four years following January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such dates."}],"balance_after":249500,"derivative":{"exercise_price":3.18,"expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-21-007550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121007550/doc4.xml","form_type":"4"}},{"id":2882015,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-03T20:00:35.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":2500,"price":10.687,"value":26717.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.32 to $11.19, inclusive. The reporting person undertakes to provide to Surface Oncology, Inc., any security holder of Surface Oncology, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":262000,"source":{"system":"sec-edgar","filing":"0001209191-21-007550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121007550/doc4.xml","form_type":"4"}},{"id":2882014,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-03T20:00:35.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":2500,"price":3.18,"value":7950.0,"ownership":{"direct":true},"balance_after":264500,"source":{"system":"sec-edgar","filing":"0001209191-21-007550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121007550/doc4.xml","form_type":"4"}},{"id":2900841,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-21T20:17:20.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall become exercisable in equal monthly installments over four years following January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such dates."}],"balance_after":252000,"derivative":{"exercise_price":3.18,"expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-004767","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121004767/doc4.xml","form_type":"4"}},{"id":2900840,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-21T20:17:20.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":5000,"price":13,"value":65000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2020."}],"balance_after":262000,"source":{"system":"sec-edgar","filing":"0001209191-21-004767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121004767/doc4.xml","form_type":"4"}},{"id":2900839,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-21T20:17:20.000Z","date":"2021-01-19","kind":"exercise","acquired":true,"shares":5000,"price":3.18,"value":15900.0,"ownership":{"direct":true},"balance_after":267000,"source":{"system":"sec-edgar","filing":"0001209191-21-004767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919121004767/doc4.xml","form_type":"4"}},{"id":2946629,"issuer":{"id":122292,"kind":"organization","name":"LogicBio Therapeutics, Inc.","symbol":"LOGC"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-14T16:45:24.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in equal installments on each of the first three anniversaries of the grant date, December 10, 2020."}],"balance_after":20000,"derivative":{"exercise_price":7.36,"expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-20-033746","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1656435/000089924320033746/doc4.xml","form_type":"4"}},{"id":3145578,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-18T16:22:30.000Z","date":"2020-05-14","kind":"grant","acquired":true,"shares":15679,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":15679,"derivative":{"exercise_price":3.95,"exercise_date":"2021-05-14","underlying":"Common Stock","underlying_shares":15679},"source":{"system":"sec-edgar","filing":"0000891839-20-000121","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1656435/000089183920000121/edgar.xml","form_type":"4"}},{"id":3284671,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-07T16:05:15.000Z","date":"2020-02-05","kind":"purchase","acquired":true,"shares":5000,"price":3.23,"value":16150.0,"ownership":{"direct":true},"balance_after":262000,"source":{"system":"sec-edgar","filing":"0001209191-20-007470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919120007470/doc4.xml","form_type":"4"}},{"id":3288905,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-05T16:05:14.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":257000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall become exercisable in equal monthly installments over four years following January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such dates."}],"balance_after":257000,"derivative":{"exercise_price":3.18,"expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":257000},"source":{"system":"sec-edgar","filing":"0001209191-20-006844","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919120006844/doc4.xml","form_type":"4"}},{"id":3288904,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-05T16:05:14.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":257000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vest in full on the date 18 months after January 21, 2020, so long as the reporting person remains an employee or other service provider of the Company on such date."}],"balance_after":257000,"source":{"system":"sec-edgar","filing":"0001209191-20-006844","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919120006844/doc4.xml","form_type":"4"}},{"id":3521114,"issuer":{"id":9673,"kind":"organization","name":"VACCINEX, INC."},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-17T17:49:22.000Z","date":"2019-05-15","kind":"grant","acquired":true,"shares":7718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first."}],"balance_after":7718,"derivative":{"exercise_price":7.78,"exercise_date":"2020-05-15","underlying":"Common Stock","underlying_shares":7718},"source":{"system":"sec-edgar","filing":"0000891839-19-000076","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1656435/000089183919000076/edgar.xml","form_type":"4"}},{"id":3619446,"issuer":{"id":109857,"kind":"organization","name":"Surface Oncology, Inc.","symbol":"SURF"},"owners":[{"id":109861,"kind":"person","name":"Goater Jeff","position":1,"cik":"0001656435","reported_name":"Goater Jeff","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-03-04T18:03:26.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments after February 12, 2019."}],"balance_after":300000,"derivative":{"exercise_price":4.27,"expiration_date":"2029-03-01","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001209191-19-015868","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718108/000120919119015868/doc4.xml","form_type":"4"}}]}